Report covers take-home points from the 2017 Gut Microbiota for Health World Summit in Paris
19 Jul 2017by GMFH Editing Team
The GMFH editing team is pleased to bring you the Gut Summit 2017 official report.
Recent advances in research have described the importance of gut microbiota in influencing interactions between the central and the enteric nervous systems. These brain-gut interactions appear to be bidirectional by means of neural, endocrine, immune, and humoral signals. Most of the data have been acquired using rodents (mice or rats) and pigs.
Gut microbiota changes may be responsible for depressive-like behaviours in mice through alterations in host metabolism
29 Jun 2016by Paul Enck
A recent study, led by Dr. Peng Xie from the Chongqing Medical University in China, has demonstrated that intestinal ‘dysbiosis’ may have a causal role in the development of depressive-like behaviours in mice through altering host metabolism.
This Chinese study aimed to characterize the gut microbiota of patients with major depressive disorder (MDD): one group of patients with acute MDD (who scored high on a depression scale, indicating clinically significant depression), called 'active-MDD', and a second group of patients with a history of MDD who had responded to treatment (achieving a 50% reduction in depression scale scores after 4 weeks of treatment), called 'responded-MDD'.
A study by De Palma, et al. used germ-free and specific pathogen-free mouse models to investigate the effects of early-life stress.
Fermented foods are not included in the recently revised ISAPP definition of probiotics, since the bacteria they contain are uncharacterized. But scientists are nevertheless studying how these foods may affect health, including brain function.
Dr. Premysl Bercik is a gastroenterologist, researcher, and Associate Professor in the Division of Gastroenterology at McMaster University in Canada.
Dr. Philippe de Timary, on the gut-brain axis in alcohol dependence
25 Nov 2014by Kristina Campbell
Philippe de Timary, MD., Ph.D., is a researcher and psychiatrist in the department of Adult Psychiatry and Institute of Neuroscience at Catholic University of Louvain and Hospital Saint-Luc in Brussels, Belgium. With a colleague, Professor Peter Starkel, he opened a clinical unit in the hospital
Speakers: Nicholas Talley (Australia), Annamaria Staiano (Italy), Marc Benninga (The Netherlands), Lukas van Oudenhove (Belgium) “The definition of functional gastrointestinal disorders (FGIDs) as laid out in the Rome III criteria is now highly questionable.” This was the view expressed
